BioCentury | Aug 1, 2020
Nabel leaves Moderna’s board to avoid conflict-of-interest concerns; plus changes at Genespire, La Jolla, Editas and more
...Moderna’s COVID-19 vaccine, mRNA-1273. Nabel is also a professor of medicine at Harvard Medical School. San Raffaele Telethon Institute for Gene Therapy...